Age-related changes in thyroid hormone profile in pediatric patients with Down syndrome

Machiko Toki1,2, Satoshi Narumi1, Junko Hanakawa2

  • 1Department of Pediatrics, Keio University School of Medicine, Tokyo 160-8582, Japan.

Endocrine Journal
|November 5, 2025
PubMed

Insights

Children with Down syndrome (DS) generally have higher thyroid-stimulating hormone (TSH) levels than controls. Thyroid hormone profiles show age-related variations, necessitating personalized thyroid function management in DS patients.

Area of Science:

  • Pediatric Endocrinology
  • Genetics and Genetic Diseases
  • Endocrinology

Background:

  • Children with Down syndrome (DS) exhibit a high incidence of thyroid dysfunction.
  • Age-related changes in thyroid hormone profiles in DS are not well understood.
  • Thyroid function monitoring is crucial for managing health in DS.

Purpose of the Study:

  • To investigate age-related changes in thyroid function in children with Down syndrome.
  • To compare thyroid hormone profiles between DS patients and age-matched controls.
  • To assess the impact of congenital heart disease (CHD) and gastrointestinal malformations on thyroid function in DS.

Main Methods:

  • Retrospective analysis of thyroid function tests (TSH, FT3, FT4) in 762 DS patients (3-14 years) without known thyroid disease.
  • Comparison with 764 age-matched controls with idiopathic short stature.
  • Analysis of thyroid hormone levels in DS patients with and without CHD and gastrointestinal malformations.

Main Results:

  • Patients with DS consistently showed higher mean TSH levels compared to controls across all age groups.
  • Mean FT3 and FT4 levels were slightly lower in the DS group after certain ages, with FT3/FT4 ratio lower in younger DS children.
  • DS patients with CHD had higher TSH levels than those without CHD after 11 years of age.

Conclusions:

  • A general rightward shift in TSH distribution indicates elevated TSH in DS patients, even without diagnosed thyroid disease.
  • Thyroid hormone profiles in DS children exhibit age-specific variations.
  • Personalized thyroid function management strategies are essential for children with Down syndrome.

Related Concept Videos

Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
4.9K
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
7.1K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
185
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
239
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
249
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
182